Article ID: CBB758085819

“Good Enough for America”: Adulterated Drugs and the 1848 Drug Import Act (2018)

unapi

In the mid-nineteenth century, the term “good enough for America” was used to identify adulterated medicines destined for the American market.3 Adulterated and counterfeit drugs were pouring into the United States. Providing poor medicines was a growing business and the market was growing with the rapid expansion of the country itself. There seemed to be little that could be done to slow or stop it. The sophistication of the adulterations was superior to available tests, standards were lacking, and there were few trained pharmacists or physicians who could apply them. There were no laws that would prohibit the importation of these products nor limit their sale once ashore. This was the situation in the late 1840s when a small group of New York pharmacists took it upon themselves to convince other health professionals and legislators that there was a problem; they devised a solution that would establish patient safety as the core value of the emerging profession of pharmacy.

...More
Citation URI
https://data.isiscb.org/isis/citation/CBB758085819/

Similar Citations

Article Alessandro Demichelis; (2018)
Understanding vaccine hesitancy: Cognitive biases and the role of trust (/isis/citation/CBB568141355/)

Article Giuseppina Pagani; (2023)
Enolito Pagani: un vino medicinale di una vecchia farmacia piemontese del XIX secolo (/isis/citation/CBB577107702/)

Book Grob, Gerald N.; (2009)
Mental Institutions in America: Social Policy to 1875 (/isis/citation/CBB000951819/)

Article Federica E. Micucci; (2021)
Construction tools of human being. The medical report (/isis/citation/CBB197399291/)

Article Christoph Gradmann; (2022)
This is the End: Eradicating Tuberculosis in Modern Times (/isis/citation/CBB676719756/)

Article Smart, Andrew; Martin, Paul; (2006)
The Promise of Pharmacogenetics: Assessing the Prospects for Disease and Patient Stratification (/isis/citation/CBB000770743/)

Article Joseph M. Gabriel; (2019)
George Urdang and the Future of Pharmacy in History (/isis/citation/CBB427402556/)

Chapter Morantz-Sanchez, Regina; (2009)
Female Patient Agency and the 1892 Trial of Dr. Mary Dixon Jones in Late Nineteenth-Century Brooklyn (/isis/citation/CBB001031388/)

Book Lukas Engelmann; Christos Lynteris; (2020)
Sulphuric Utopias: A History of Maritime Fumigation (/isis/citation/CBB525197034/)

Article Briony Hudson; (2019)
Challenging Collections and Collecting Challenges (/isis/citation/CBB379724741/)

Article Michael A. Flannery; (2019)
Government as Apothecary: Civil War Pharmacy and the Common Good (/isis/citation/CBB555475771/)

Book Maki Umemura; (2011)
The Japanese Pharmaceutical Industry: Its Evolution and Current Challenges (/isis/citation/CBB223408454/)

Book Greene, Jeremy A.; Watkins, Elizabeth Siegel; (2012)
Prescribed: Writing, Filling, Using, and Abusing the Prescription in Modern America (/isis/citation/CBB001214574/)

Authors & Contributors
Giuseppina Pagani
Micucci, Federica E.
Demichelis, Alessandro
Bovone, Giulia
Mackintosh, Alan
Dorner, Zachary
Journals
Pharmacy in History
Atti e Memorie, Rivista di Storia della Farmacia
Medicina Historica
Mefisto: Rivista di medicina, filosofia, storia
Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences
Social History of Medicine
Publishers
University of Chicago Press
Transaction
Routledge
MIT Press
Johns Hopkins University Press
Columbia University
Concepts
Pharmacy
Medicine and society
Pharmaceutical industry
Public health
Medicine
Patients
People
Urdang, George
Jones, Mary Dixon
Time Periods
19th century
20th century
21st century
18th century
20th century, late
20th century, early
Places
United States
England
Italy
Americas
Argentina
Japan
Institutions
Institut Pasteur, Paris
Comments

Be the first to comment!

{{ comment.created_by.username }} on {{ comment.created_on | date:'medium' }}

Log in or register to comment